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Results A total of 388 clinicians from 44 countries 
answered to the survey. Most of them were medical doc-
tors (93%), and their primary field of practice was geriat-
rics (83%). Two hundred and five clinicians (52.8%) always 
assessed frailty in their daily practice, 38.1% reported to 
“sometimes” measure it, and 9.1% never assess it. A sub-
stantial proportion of clinicians (64.9%) diagnose frailty 
using more than one instrument. The most widely used tool 
was the gait speed test, adopted by 43.8% of the clinicians, 
followed by clinical frailty scale (34.3%), the SPPB test 
(30.2%), the frailty phenotype (26.8%) and the frailty index 
(16.8%).
Conclusion A variety of tools is used to assess frailty of 
older patients in clinical practice highlighting the need for 
standardisation and guidelines.
Abstract 
Introduction Various operational definitions have been 
proposed to assess the frailty condition among older indi-
viduals. Our objective was to assess how practitioners 
measure the geriatric syndrome of frailty in their daily 
routine.
Methods An online survey was sent to national geriatric 
societies affiliated to the European Union Geriatric Medi-
cine Society (EUGMS) and to members of the European 
Society for Clinical and Economic Aspects of Osteoporo-
sis, Osteoarthritis and Musculoskeletal Diseases (ESCEO).
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Introduction
Frailty is a major syndrome associated with ageing [1]. 
This geriatric situation represents a huge potential pub-
lic health issue at both the patient and the societal levels 
because of its multiple clinical, economic and societal con-
sequences [2–5]. From a recent systematic review, it has 
been shown that frailty was associated with an increased 
risk of mortality, loss of activities in a normal daily routine, 
hospitalisation, physical limitations, falls and fractures [5].
Because of the high prevalence and the severity of such 
adverse outcomes, screening should be a priority, espe-
cially in primary care and taking advantage of any possible 
contact between the individual and the health care system 
[6–8]. Assessing frailty could indeed precociously identify 
persons at high risk of negative outcomes, theoretically 
allowing the timely implementation of preventive/therapeu-
tic countermeasures.
Over the years, many models of frailty have been pro-
posed. These models try to define the term frailty and 
construct a number of measurement tools to establish the 
frailty status of an individual. The most widely cited items 
on physical markers of frailty are based on the accumula-
tion of deficits in physical, cognitive, mental health and 
functional domains. In a recent systematic review, 79 origi-
nal or adapted frailty instruments were identified, but only 
5 were linked to all 5 components of the International Clas-
sification of Functioning, Disability, and Health [9].
Major differences in the assessment of frailty exist 
in the clinical practice when taking care of older people 
[10]. Even the use of the same tools could be different, as 
recently highlighted in a study showing that geriatricians 
more often judge patients as frail compared to family phy-
sicians [11].
The variability in the operational definitions might be 
acceptable from a public health perspective, because the 
choice of an instrument should largely rely on the interven-
tion to put eventually in place, the available resources and 
clinical priorities, factors that are extremely variable across 
settings and regions. At the same time, the identification of 
a gold standard measure might still be important to obtain 
because it represents the only way for providing to the con-
struct of a nosological entity to the often ambiguous frailty 
condition [12].
To our knowledge, the frequency in the use of tools for 
the assessment of frailty and the components of this geriat-
ric syndrome has never been estimated. Consequently, we 
designed an online survey with the objective to collect data 
looking at the proportion of clinicians assessing frailty in 
their daily practice and at the tools used by these clinicians.
Materials and methods
An online survey using a self-administered questionnaire 
was designed to collect information on the tools used by 
clinicians for assessing frailty in their clinical practice. 
Responses to all questions were categorised but with the 
possibility to provide some open comments. The tools 
commonly used to assess frailty and then proposed in the 
questionnaire are presented in Table 1.
The reasons why clinicians assessed frailty in their 
practice were also collected using predefined options. The 
clinician was specifically asked to consider his/her clini-
cal practice directed towards subjects aged 60  years and 
older. Moreover, questions related to the assessment of 
domains traditionally considered as constituent of frailty 
(i.e. physical performance, nutritional status, cognitive sta-
tus, biological markers, quality of life, depression, sensorial 
impairment and body composition) were also asked, using 
predefined categories, with the possibility to provide open 
answers. The same technique was used to collect the socio-
demographic information of the clinician (e.g. country of 
residence, age, work place, profession).The time to com-
plete the survey was around 5 min.
The survey was sent in January 2016 through two differ-
ent channels. The first was the European Union Geriatric 
Medicine Society (EUGMS) office that forwarded the sur-
vey to all their affiliated societies who then forwarded it to 
their individual members. The second was a direct contact, 
via email, to all members of the European Society for Clin-
ical and Economic Aspects of Osteoporosis, Osteoarthritis 
and Musculoskeletal Disorders (ESCEO).
Quantitative variables were expressed as means and 
standard deviations (SD) and qualitative variables as num-
bers and percentages. Analyses of variances were used to 
compare the prevalence of frailty assessment among differ-
ent groups of clinicians. Results were considered to be sta-
tistically significant at the 5% critical level (p < 0.05). All 
calculations were performed using Statistica 10 software.
Results
Three hundred and eighty-eight clinicians from 44 coun-
tries answered the survey. Most of the answers were 
obtained from Italy, Spain, Belgium and the United King-
dom (72.4% in total). Geriatrics was the most widely cited 
field of interest (83.6%), followed by rheumatology (6.6%) 
and endocrinology (3.4%). The vast majority of the clini-
cians were medical doctors (88.7%). Clinicians were on 
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average 48.7 ± 12.1  years old, and 51.8% of them were 
men.
Two hundred and five clinicians (52.8%) always assessed 
frailty in their daily practice, 38.1% reported to “some-
times” measure it, and 9.1% never assess it. Consequently, 
frailty was assessed in the routine practice by 90.9% of 
the respondents. As expected, the frequency of the frailty 
assessment was higher among geriatricians (94.9%) com-
pared with other specialities (75.4%; p < 0.0001). The 
most widely reported tool used to assess frailty was the 
gait speed (43.8%), followed by the clinical frailty scale 
(34.3%), the SPPB test (30.2%) and the Frailty Pheno-
type also known as the Fried Criteria (26.8%; Table  2). 
Among clinicians who assessed frailty with the frailty phe-
notype (i.e. 26.8%), 48.2% of them used the original ver-
sion; 32.1% used an adapted version, whereas 19.7% did 
not know which version they used. It is important to note 
that 41.2% of clinicians assess frailty with a tool that was 
Table 1  Description of the tools commonly used to assess frailty
Tool used to assess frailty Description of the tools
Gait speed [13] To assess physical performances, gait speed, which is a component of the SPPB test, is also proposed by 
the EWGSOP. A score <0.8 m/s for walking speed is considered as poor physical performances
Clinical frailty scale [14] This is based on a clinical evaluation in the domains of mobility, energy, physical activity and function, 
using descriptors and figures to stratify elderly adults according to their level of vulnerability. The 
score ranges from 1 (robust health) to 7 (complete functional dependence on others)
SPPB [13] The short physical performance battery (SPPB) test is composed of three separate tests: balance, 
4-metre gait speed and chair stand test. A score between 0 and 4 is assigned for each test, and the three 
tests are weighted equally. Therefore, the maximum score is 12 points. The cut-off value used to assess 
a poor physical performance is ≤8 points, according to the European working group on Sarcopenia in 
older people (EWGSOP)
Frailty phenotype [15]
(i.e. fried criteria)
This is a deficit across five domains. Thus, phenotype of frailty was identified by the presence of three 
or more of the following components: shrinking, weakness, poor endurance and energy, slowness and 
a low level of physical activity. The presence of one or two deficits indicates a pre-frail condition, and 
a total of three or more deficits indicates frailty, while the absence of deficits indicates a robust state
Frailty index [16] This is expressed as a ratio of deficits present to the total number of deficits considered. Frailty index 
includes 40 variables and the calculation was performed on the maximum number of deficits col-
lected. Thus, participants were considered as frail when the ratio of deficits present to the total number 
of deficits considered was 0.25 (i.e. lowest quartile) or more
Edmonton frail scale [17] This samples 8 domains (cognitive impairment, health attitudes, social support, medication use, nutri-
tion, mood, continence, functional abilities). A score range between 0 and 3 is a robust state, 4–5 is a 
slightly frail state, 6–8 is a moderately frail state and 9–17 is a severely frail state
Frail scale status [18] This has 5 components: fatigue, resistance, ambulation, illness and loss of weight. Scores range from 0 
to 5 and represent frail (3–5), pre-frail (1–2) and robust (0) health states
Gerontopole frailty screening tool [19] This is an 8-item questionnaire intended to help general practitioners identify frailty in community-
dwelling persons 65 years or older without functional disability or current acute disease. The first 6 
questions evaluate the patient’s status (living alone, involuntary weight loss, fatigue, mobility difficul-
ties, memory problems and gait speed), whereas the last two assess the general practitioner’s personal 
view about the frailty status of the individual and the patient’s willingness to be referred to the Frailty 
Clinical for further evaluation
SHARE frailty instrument [20] Using the five SHARE frailty variables (fatigue, loss of appetite, grip strength, functional difficulties 
and physical activity), D-factor scores (DFS) were determined using the SHARE-FI formula, and 
based on the DFS value, the subject could then be categorised as non-frail, pre-frail or frail
SEGA grid [21] This establishes a risk profile of frailty and provides reporting of problems and factors that may influ-
ence functional decline, including age, provenance, drugs, mood, perceived health, history of falls, 
nutrition, comorbidities, IADL, mobility, continence, feeding and cognitive functions. A score of 0, 1 
or 2 is given for each item and a total over 11 points indicates a “very frail” condition; a score between 
8 and 11 points indicates a frail condition, while a score below 8 is a slightly frail condition
Groningen frailty indicator [22] This consists of 15 self-report items and screens for loss of functions and resources in four domains: 
physical, cognitive, social, and psychological. Scores range from zero (not frail) to fifteen (very frail). 
A GFI score of 4 or higher was regarded as frail
Strawbridge questionnaire [23] This defines frailty as difficulty in two or more functional domains (physical, cognitive, sensory and 
nutritive). A score greater than or equal to 3 in more than one domain is considered vulnerable
Tilburg frailty indicator [24] It consists of 2 parts. Part A contains 10 questions on determinants of frailty and diseases (multimorbid-
ity); part B contains 3 domains of frailty (quality of life, disability and health care utilisation) with a 
total of 15 questions on components of frailty. The threshold above which the participant is considered 
as frail is 5 points
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not proposed in the survey, and that 64.9% diagnose frailty 
using more than one instrument. The gait speed test and 
the SPPB are widely used in combination with another tool 
to assess frailty (in 89.3 and 73.3% of cases, respectively). 
These tools included LASA Physical Activity Question-
naire, the Physical Activity Scale for the Elderly (PASE), 
the Health Assessment Questionnaire (HAQ), the Short 
QUestionnaire to ASsess Health-enhancing physical activ-
ity (SQUASH), clinical history or self-made questionnaire.
It is interesting to note that a similar pattern is observed 
in European countries and non-European ones. The most 
used tool was in both cases the gait speed (42.9% in Europe 
and 54.8% in the rest of the world). The Clinical Frailty 
Scale was used by 34.4% of the clinicians in Europe and by 
33.3% out of Europe. The SPPB test was used by, respec-
tively, 30.6 and 26.2% of the clinicians in Europe and out 
of Europe. Our survey also highlighted that clinicians 
working in a University or a University Hospital were not 
more likely to use frailty assessment tools than their coun-
terparts working in general hospitals.
Among the most widely adopted tools, a specific cut-
off was used by 35.3% of the clinicians for gait speed and 
by 24.8% of the clinicians for the SPPB. Almost half of 
the clinicians using the SPPB in their clinical practice 
(44.8%) used the 8-point cut-off. Among those who 
assessed gait speed in their clinical practice, 64.9% used 
the cut-off of 0.8 m/s to diagnose frailty.
The most frequently cited reasons why clinicians 
always assess frailty in their clinical practice were (1) 
frail older people are at high risk of adverse outcomes 
(i.e. falls, hospitalisations and death), and (2) its pres-
ence may affect the clinical decision. It is noteworthy 
that 71.6% of the clinicians always assess frailty because 
of a combination of several factors. The combination 
“because it is recommended to measure frailty among 
older people” AND “because the prevalence of frailty is 
high” AND “because frail older people are at high risk of 
falls, hospitalisations and death” AND “because its pres-
ence may affect the clinical decision” was the most fre-
quently reported combination, reported by 13 clinicians 
(6.84%) (Table 3).
Among those who “sometimes” assess frailty, the most 
frequent reasons for conducting the evaluation are that 
(1) the patient seems frail (12.2%) and (2) the clinician 
may change his clinical decision according to the results 
of the test (7.43%). Around 63% of the clinicians assess 
frailty when several combined factors are observed, 
mainly when “the patient seems frail” AND “the patient 
has a low BMI (<21  kg/m²)” AND “the patient seems 
under-nourished” (2.03%) (Table 4).
Lastly, the main reasons for never evaluating frailty 
(n = 35) are because clinicians have no time (12.5%), 
they think that there are no appropriate tools to assess 
frailty in clinical practice (9.38%), the results of such 
Table 2  Tools used to assess frailty in clinical practice
Tool used Number Frequency (%)
Gait speed 170 43.8
Clinical frailty scale 133 34.3
SPPB 117 30.2
Frailty phenotype (i.e. Fried criteria) 104 26.8
Frailty index 65 16.8
Frail scale status 47 12.1
Edmonton frail scale 36 9.28
Gerontopole frailty screening tool 28 7.22
SHARE frailty instrument 16 4.12
SEGA grid 15 3.87
Groningen frailty indicator 10 2.55
Strawbridge questionnaire 8 2.06
Tilburg frailty indicator 5 1.29
Other 160 41.2
Table 3  Main reasons given by 
clinicians for always assessing 
frailty (n = 205)
Reasons Number Frequency (%)
Because frail older people are at high risk of falls, hospitalisations, death 21 10.3
Because its presence may affect my clinical decision 19 9.25
Because the prevalence of frailty is high 8 3.90
Because it is recommended to measure frailty among older people 6 2.93
Other 15 7.32
Combination of several factors 136 66.3
Table 4  Main reasons given by clinicians for sometimes assessing 
frailty (n = 148)
Reasons Number Frequency (%)
When the patient seems frail 18 12.2
When I may change my clinical deci-
sion according to the result of the test
11 7.43
When I have time 10 6.76
When I think about it 4 2.70
Other 11 7.43
Combination of several factors 94 63.51
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assessment do not substantially change the clinical deci-
sion (9.38%), clinicians do not feel competent to diag-
nose frailty (9.38%) and for a combination of several fac-
tors (n = 59.36%).
Besides the specific tools used in the diagnosis of frailty, 
other assessments that help to have a better view of the 
frailty status of the patient were performed by the clinicians 
(Table  5). They could be used as complementary tools 
Table 5  Assessment of frailty 
components in addition or in 
the absence of an operational 
diagnosis of frailty
Frailty component Specific tool Number Frequency (%)
Functional status
SPPB test 158 40.7
Gait speed 217 55.9
Grip strength 158 40.7
Other 39 10.1
Nutritional status
MNA (mini nutritional assessment) 221 56.9
MUST (malnutrition universal screening tool) 42 10.8
NRS (nutrition risk screening) 20 5.15
Cognitive status
MMSE (mini mental state examination) 297 76.5
CRD (clinical dementia rating scale) 105 27.1
FCSRT (free and cued selective reminding test) 7 1.8
Executive function (i.e. memory, anxiety, attention) 84 21.6
GDS (geriatric depression scale) 257 66.2
Raskin depression scale 7 1.8
Covi anxiety scale 5 1.29
NPI scale 114 29.4
Autonomy
ADL (activity daily living) 261 67.3
IADL (instrumental activity daily living) 246 63.4
Other 43 11.1
Sensorial impairment
Sensorial 114 29.4
Vision 157 40.5
Monoyer-parinaud scale 26 6.7
Amsler scale 25 6.4
Audition 109 28.1
HHIES (hearing handicap inventory for the elderly) 27 6.9
Biological markers
IL-6 20 5.15
IGF-1 21 5.41
Vitamin D 213 54.9
Body composition
BIA (bioelectrical impedance analysis) 72 18.6
DXA (dual-energy X-rays absorptiometry) 64 16.5
CT scan 19 4.89
MRI (magnetic resonance imaging) 15 3.87
Anthropometric values 75 19.3
Level of physical activity
Questionnaire 62 15.9
Physical exhaustion or early fatigability 157 40.5
Objective measurement 73 18.8
Quality of life 144 37.1
Socio-demographic data 292 75.3
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after the operational diagnosis of frailty or for the general 
assessment of health status in the absence of a formal diag-
nosis of frailty. Functional status was measured by 79.4% 
of the clinicians, autonomy by 82.7%, nutritional status by 
79.9%, cognitive status by 90.9%, sensorial impairment by 
40.5%, biological markers by 60.1%, body composition by 
40.5% and quality of life by 37.1%. However, among clini-
cians assessing at least one of these components of frailty, 
the tools used are different even if some particular tools are 
more widely used than others (e.g. MMSE and MNA).
Discussion
The results of this survey highlight that multiple tools are 
used by clinicians to assess frailty. Moreover, even if the 
same tool might be used, a heterogeneity about the choice 
of the thresholds of risk also exists, as shown for the gait 
speed and the SPPB test. It is also important to note that 
in the absence of a consensual and operational definition 
of frailty, a lot of tools are used by the clinician for the 
general assessment of the health status of the subject aged 
over 65 years even in the absence of a formal diagnosis of 
frailty.
Interestingly, several frailty measurements used had not 
been robustly validated in the literature, and their prognos-
tic ability was rarely determined. Moreover, many were 
modified from their original, validated version, potentially 
impacting on the replicability and comparability of the find-
ings. Consistently with Theou and colleagues who reported 
the existence of 262 different versions of frailty phenotype 
[25], 32.1% of the respondents to our survey declared using 
a modified version of this operational definition.
It has been suggested, in the literature, that some of 
the tools used by clinicians are better for population-level 
frailty screening, whereas others are best suited for clini-
cal screening, or for clinical assessment. Even if it was not 
the objective of the present survey, we believe it is also 
important to underline the difference between the concept 
of screening and the concept of diagnosis. The primary 
purpose of screening tests is to detect risk factors for dis-
ease in large numbers of apparently healthy individuals. 
The purpose of a diagnostic test is to establish the presence 
of disease in symptomatic or screening-positive individu-
als. Only the latter point is a basis for treatment decisions. 
Consequently, the tools to be used should be differentiated 
according to the purpose of the assessment [26]. This is 
probably a limitation of the present survey since we did not 
specifically ask whether the assessment of frailty was con-
ducted for screening or diagnosing.
Currently, various tools are proposed to assess frailty but 
none has been able to prevail as superior to the others. The 
ideal scoring system for defining frailty should be able to 
assess all domains of frailty and their severity, as well as to 
be easily applicable to the daily clinical practice in order to 
measure changes occurring over time (especially after sig-
nificant medical or surgical interventions) [27]. However, 
because of the multifactorial nature of frailty, it is difficult 
to construct a model that is both highly accurate and easy 
to use. However, it should be acknowledged that the psy-
chometric properties requested for a screening or a diagno-
sis tool are not similar, a high accuracy for the diagnosis 
instrument and a fast and easy use for the screening tool.
According to a systematic review, the main factors asso-
ciated with frailty are age, female gender, ethnic group, 
education, income, cardiovascular diseases, number of 
comorbidities, functional incapacity, poor self-rated health, 
depressive symptoms, cognitive function, body mass index, 
smoking and alcohol use [28]. Most of this information is 
routinely collected by clinicians. Interestingly, the cogni-
tive domain of frailty is largely assessed with more than 
90% of clinicians taking it into account. This is important 
because there is increasing evidence that cognitive decline 
synergistically acts with physical frailty to accelerate the 
trajectory towards disability [29–33]. However, the tools 
used by the clinicians to assess cognitive function are quite 
heterogeneous as well.
Even if this study had primarily a European perspective, 
we received some information from clinicians living out-
side Europe. Because of the few responses received, com-
parative analysis could not be performed. However, looking 
at the literature from developing countries, the frailty phe-
notype is widely diffused although the Frailty Index and the 
Edmonton Frailty Scale are also commonly used [34, 35]. 
In regions where health care resources are scarce, many 
health conditions frequently remain undiagnosed or are 
overlooked. Moreover, the lack of equipment and/or trained 
staff is another possible issue affecting the frailty assess-
ment [34]. Moreover, it should be acknowledged that very 
few assessment tools have been fully validated in low- and 
medium-income countries.
Even in developed countries, different strategies and 
tools to assess frailty might be needed according to the 
clinical setting [36]. Given the magnitude of the challenges 
that frailty poses for the health care systems as currently 
organised, policy changes will be essential. To systemati-
cally implement the frailty assessment (i.e. as screening or 
as diagnosis), a number of policy changes are required, as 
proposed by the Canadian frailty network [36]. A common 
language needs to be used among researchers, health care 
providers, administrators, policy makers and the public, 
particularly in the definition of frailty. Researchers and cli-
nicians need to identify and agree on which validated frailty 
tools to use in which setting. Before the full diagnosis of 
frailty by the clinician specialist, a consensus is needed on 
whom to screen. Possible approaches include screening all 
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individuals over a certain age who come into contact with 
the health care system, or screening on the basis of selected 
criteria such as age, selected medical conditions, psychoso-
cial disorders, falls or functional disability, high use of the 
health care system and change in living situation such as 
moving from independent to assisted accommodation.
In conclusion, frailty (in its physical and cognitive com-
ponents) is regularly assessed by clinicians working with 
older subjects, using different standardised tools. A bet-
ter understanding of the prognostic characteristics of such 
tools is needed to inform clinicians about these choices.
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